Prevalence of tinea facei and tinea capitis in rural population of chitradurga in India

Nagaral, Girish V.; Patil, Sudha; G.K, Veerabhadra Goud; Jagadevi,

doi:10.18231/2581-4729.2019.0007

Cited by 1 publication

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Male predominance of suffering of both Tinea corporis and Tinea cruris reported in these studies. 3,13 The male predominance might be due to the fact that the males are more commonly engaged in outdoor activity and, hence, they are wearing relatively tight fitted cloth than female. Prolonged wearing of wet cloth (due to sweating) provide risk factor for tinea infection.…”

Section: Discussionmentioning

confidence: 99%

“…1 Globally, the prevalence of superficial fungal skin infection is 20-25%, and it is comparatively higher in all age groups of both sexes in the tropical regions. 2,3 In India, the prevalence is ranging from 36.6% to 78.4%. 4 Dermatophytes are the most common organism which causes superficial infections, sometimes it's named as Tinea infection or dermatophytosis.…”

Section: Introductionmentioning

confidence: 99%

“…5,6 Tinea infections are mostly cutaneous and restricted to non-living confide layers as the dermatophytes cannot able to penetrate the deeper tissues or organs of immunocompetent hosts. 3 The characteristic lesion is a circular, single or multiple sites and usually well demarcated; edge become raised with pink to slightly erythematous patch. In progressive cases, central area become clear and scaling may present at the border.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Comparison of Efficacy between Topical Luliconazole and Topical Clotrimazole in the Treatment of Tinea Corporis and Tinea Cruris

Rashel ATM,

Chowdhury MAN,

Das HS

et al. 2023

JSWMC

View full text Add to dashboard Cite

Background: The prevalence of Tinea Corporis and Tinea Cruris infections are increasing in Bangladesh due to its tropical climate, along with low socio-economic conditions. In treatment of these infections, Clotrimazole has been used for a long time. But Luliconazole is a newer drug which is offering more efficacy and tolerability with a short duration of treatment. Methods: An observational comparative study was directed to assess the efficacy of topical Luliconazole over Clotrimazole in the treatment of Tinea Corporis and Tinea Cruris among the 175 OPD patients of Department of Dermatology and Venereology, Sylhet MAG Osmani Medical College Hospital. The patient’s score was followed up by using 4-point scale of Global Assessment Score. Results: The mean age of Group A patients was 33.94±13.95 years and Group B was 32.64±13.15 years and male patients were predominant in both groups (65.2% and 66.3%). Tinea corporis was more prevalent in both groups (65.2% and 70.9%). The mean number of infection lesion was 2.35±1.12 and 2.30±1.13. The mean duration of infections was 3.33±5.98 months and 2.38±3.36 months in respective study groups. Papules found 61.4% and 51.4% among the patients respectively. Based on GAS, at the end of first week of treatment, significant difference in distributions found in case of erythema and papules. At the end of treatment, significant difference in distributions found in case of pruritus and scaling. At the 4 weeks after the end of treatment, significant difference in distributions found in case of pruritus, erythema and scaling (p<0.005). The mean GAS of Group A was 6.95±1.05 at baseline, which gradually decreased to 3.16±1.27, 1.02±1.01 and 0.42±1.32 in respective first, second and third visit. On the other side, in Group B, the mean GAS decreased from 7.21±1.27 to 3.87±1.28, 1.33±1.37 and 1.23±2.01 in respective baseline, first, second and third visit. Complete cure observed more patients in Group A (32.6%) compared to Group B (12.8%) after one weeks of treatment, whereas no response to treatment observed in more patients of Group B (55.8%) compared to Group A (28.1%). These changes in distribution were found significant (p=0.004). At the second visit, complete cure found in 89.9% patients in Group A and 77.9% patients in Group B. These distributions were reached the level of significance (p=0.031). At the last visit, only 2.2% of the completely cured patients of Group A and 16.3% of the completely cured patients of Group B developed relapse of the disease, which was also found significantly (p=0.001). Conclusion: Luliconazole found to be superior in terms of short duration of treatment course, less treatment failure and less relapse compared to that of the Clotrimazole.

show abstract

Section: Discussionmentioning

confidence: 99%